Nicole Luosey

Vice President, Strategic and Program Operations

Nicole Luosey is the Vice President of Strategic and Program Operations at Cadent Therapeutics. Ms. Luosey most recently was Vice President, Program Management at Syntimmune where she led investor activities and diligence and integration efforts of the acquisition by Alexion.  Previously, she was Vice President, Program Management at Dimension Therapeutics (acquired by Ultragenyx) where she built the program and alliance management function. Prior to Dimension Therapeutics, Ms. Luosey held other positions of growing responsibilities in program and alliance management at EMD Serono, Merrimack Pharmaceuticals, and Dyax Corp (acquired by Shire).

Ms. Luosey is a certified Project Management Professional (PMP) and received her Masters degree in Program Management at Boston University and her B.F.A from the University of Hartford.

Our Team

Nicole Luosey

Vice President, Strategic and Program Operations

Nicole Luosey is the Vice President of Strategic and Program Operations at Cadent Therapeutics. Ms. Luosey most recently was Vice President, Program Management at Syntimmune where she led investor activities and diligence and integration efforts of the acquisition by Alexion.  Previously, she was Vice President, Program Management at Dimension Therapeutics (acquired by Ultragenyx) where she built the program and alliance management function. Prior to Dimension Therapeutics, Ms. Luosey held other positions of growing responsibilities in program and alliance management at EMD Serono, Merrimack Pharmaceuticals, and Dyax Corp (acquired by Shire).

Ms. Luosey is a certified Project Management Professional (PMP) and received her Masters degree in Program Management at Boston University and her B.F.A from the University of Hartford.

Our Team

Nicole Luosey

Vice President, Strategic and Program Operations

Nicole Luosey is the Vice President of Strategic and Program Operations at Cadent Therapeutics. Ms. Luosey most recently was Vice President, Program Management at Syntimmune where she led investor activities and diligence and integration efforts of the acquisition by Alexion.  Previously, she was Vice President, Program Management at Dimension Therapeutics (acquired by Ultragenyx) where she built the program and alliance management function. Prior to Dimension Therapeutics, Ms. Luosey held other positions of growing responsibilities in program and alliance management at EMD Serono, Merrimack Pharmaceuticals, and Dyax Corp (acquired by Shire).

Ms. Luosey is a certified Project Management Professional (PMP) and received her Masters degree in Program Management at Boston University and her B.F.A from the University of Hartford.

Our Team